News & Analysis on Clinical Trial Services & Contract Research And Development
The drug industry needs to rethink what defines a ‘high-risk’ candidate say an expert calling for more detailed pharmacological studies in the wake of the BIA 10-2474 tragedy.
The US FDA has detailed GMP violations that prompted it to ban the importation of drugs made at an Emcure Pharmaceuticals plant in India last year.
The changeover time between batches is significantly quicker using disposable equipment, says Avid Bioservices whose new biomanufacturing facility boasts several 1,000L single-use bioreactors.
TxCell has hired Caladrius Biosciences’ subsidiary PCT as its manufacturer in the US and has started looking for a CMO in Japan.
CORRECTION
Valeant is offloading the contract manufacturing business of ophthalmology and neurosurgery medical devices firm Synergetics, acquired last October.
Security is the top priority for the database intended to stop fake drugs entering European supply chains according to EFPIA.
dispatches from DCAT Week '16
AAI Pharma Services (AAI) and Cambridge Major Laboratories (CML) have rebranded as Alcami, a contract development and manufacturing organization.